217 related articles for article (PubMed ID: 8884319)
1. The serum levels of soluble interleukin-2 receptor levels in patients with obstructive jaundice.
Yüceyar H; Kokuludag A; Coker A; Ersöz G; Keskinoglu A; Güler A; Cavusoglu H
Hepatogastroenterology; 1996; 43(10):949-53. PubMed ID: 8884319
[TBL] [Abstract][Full Text] [Related]
2. [Serum levels of soluble interleukin-2 receptor in alcoholic patients].
Sopeña B; Fernández-Rodríguez CM; Martínez Vázquez C; Méndez MX; de la Fuente J; Freire M; Arnillas E; Outon A
An Med Interna; 1998 Apr; 15(4):189-93. PubMed ID: 9608061
[TBL] [Abstract][Full Text] [Related]
3. Soluble interleukin-2 receptor and soluble CD8 in liver cirrhosis and obstructive jaundice.
Wagner F; Assemi C; Lersch C; Hart R; Classen M
Clin Exp Immunol; 1990 Nov; 82(2):344-9. PubMed ID: 2122935
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of interleukin-10, interleukin-12 and soluble interleukin-2 receptor in chronic liver disease type C.
Kitaoka S; Shiota G; Kawasaki H
Hepatogastroenterology; 2003; 50(53):1569-74. PubMed ID: 14571788
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B
Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of soluble interleukin-2 receptor in patients with ANCA-associated vasculitis.
Arranz O; Ara J; Rodríguez R; Saurina A; Mirapeix E; Darnell A
J Nephrol; 2000; 13(1):59-64. PubMed ID: 10720216
[TBL] [Abstract][Full Text] [Related]
7. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
[TBL] [Abstract][Full Text] [Related]
8. Soluble interleukin-2 receptors in sera of children with primary malignant neoplasms.
Bodey B; Psenko V; Lipsey AL; Kaiser HE
Anticancer Res; 1996; 16(1):219-24. PubMed ID: 8615612
[TBL] [Abstract][Full Text] [Related]
9. Increased serum soluble interleukin 2 receptor levels in patients with viral liver diseases.
Yamaguchi S; Onji M; Ohta Y
Hepatogastroenterology; 1988 Oct; 35(5):245-8. PubMed ID: 3068111
[TBL] [Abstract][Full Text] [Related]
10. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy.
Dejica D
Roum Arch Microbiol Immunol; 2001; 60(3):183-201. PubMed ID: 12165973
[TBL] [Abstract][Full Text] [Related]
11. [Changes and significance of peripheral blood T cell subsets, soluble interleukin-2 receptor and interferon-gamma in patients with retreatment pulmonary tuberculosis and initial treatment tuberculosis].
Zhang SJ; Xiao HP
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Dec; 34(12):884-7. PubMed ID: 22333498
[TBL] [Abstract][Full Text] [Related]
12. Increased frequency of interferon-gamma-producing peripheral blood CD4+ T cells in chronic hepatitis C virus infection.
Kawakami Y; Nabeshima S; Furusyo N; Sawayama Y; Hayashi J; Kashiwagi S
Am J Gastroenterol; 2000 Jan; 95(1):227-32. PubMed ID: 10638589
[TBL] [Abstract][Full Text] [Related]
13. Relationship between serum levels of soluble interleukin-2 receptor and various disease parameters in patients with squamous cell carcinoma of the esophagus.
Oka M; Hazama S; Takahashi M; Yamamoto K; Abe T; Yoshino S; Hayashi H; Tangoku A
Hepatogastroenterology; 1999; 46(28):2254-9. PubMed ID: 10521976
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of serum levels of soluble interleukin-2 receptor in patients with localized scleroderma.
Ihn H; Sato S; Fujimoto M; Kikuchi K; Takehara K
Br J Dermatol; 1996 May; 134(5):843-7. PubMed ID: 8736323
[TBL] [Abstract][Full Text] [Related]
15. Changes in the levels of serum-soluble interleukin-2 receptor after surgical stress.
Murakami S; Sakata H; Tsuji Y; Okubo K; Takahashi T; Kikuchi M; Hirayama R
Surg Today; 2003; 33(8):565-70. PubMed ID: 12884092
[TBL] [Abstract][Full Text] [Related]
16. Anti asialoglycoprotein receptor antibodies and soluble interleukin-2 receptor levels as marker for inflammation in autoimmune hepatitis.
Dejica D; Treichel U; Pár A; Chira O; Meyer zum Büschenfelde KH
Z Gastroenterol; 1997 Jan; 35(1):15-21. PubMed ID: 9123953
[TBL] [Abstract][Full Text] [Related]
17. High serum values of soluble CD154, IL-2 receptor, RANKL and osteoprotegerin in Langerhans cell histiocytosis.
Ishii R; Morimoto A; Ikushima S; Sugimoto T; Asami K; Bessho F; Kudo K; Tsunematu Y; Fujimoto J; Imashuku S
Pediatr Blood Cancer; 2006 Aug; 47(2):194-9. PubMed ID: 16358318
[TBL] [Abstract][Full Text] [Related]
18. Effects of cyclosporine A on serum and urinary soluble interleukin-2 receptor in patients with lupus nephritis.
Tang Z; Zhang J; Zhang S; Li L
Chin Med J (Engl); 1997 Sep; 110(9):686-9. PubMed ID: 9642325
[TBL] [Abstract][Full Text] [Related]
19. The relationship between protein kinase C signal pathway and the immunologic evaluation in patients with obstructive jaundice.
Zou S; Wang J
Zhonghua Wai Ke Za Zhi; 2001 Dec; 39(12):897-900. PubMed ID: 16201164
[TBL] [Abstract][Full Text] [Related]
20. Aspirin reduces serum anti-melanocyte antibodies and soluble interleukin-2 receptors in vitiligo patients.
Zailaie MZ
Saudi Med J; 2005 Jul; 26(7):1085-91. PubMed ID: 16047057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
